Zha S, Li Z, Chen C, Du Z, Tay JC, Wang S
Immunotherapy 2019, 11: 967
https://www.futuremedicine.com/doi/abs/10.2217/imt-2018-0211
« CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells »